Publications
Jan 9, 2025
- bioRxiv [Preprint]
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters.
da Silva Antunes R, Fajardo-Rosas V, Yu ED, Gálvez RI, Abawi A, Alexandar Escarrega E, Martínez-Pérez A, Johansson E, Goodwin B, Frazier A, Dan JM, Crotty S, Seumois G, Weiskopf D, Vijayanand P, Sette A
Feb 24, 2025
- JCI Insight
Frequency of dengue virus-specific T cells is related to infection outcome in endemic settings
Gálvez RI, Martínez-Pérez A, Escarrega EA, Singh T, Zambrana JV, Balmaseda Á, Harris E, Weiskopf D
Jan 16, 2025
- Curr Pharm Biotechnol
A Roadmap Towards the Identification and Validation of Conserved T Cell Epitope Regions in Viral Pathogen Families with Pandemic Potential
Grifoni A, Sidney J, Weiskopf D, Scheuermann RH, Sette A
Mar 24, 2025
- J Natl Cancer Inst
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patients
Mack PC, Crawford JM, Chang A, Yin A, Klein SL, Shea P, Hirsch FR, Zidar D, Simon V, Gleason C, McBride R, Cordon-Cardo C, VanOudenhove J, Halene S, Lee FE, Mantis N, Kushi LH, Weiskopf D, Merchant A, Reckamp KL, Skarbinski J, Figueiredo JC
Jan 12, 2025
- Vaccine
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial
Thiem VD, Anh DD, Ha VH, Van Thom N, Thang TC, Mateus J, Carreño JM, Raghunandan R, Huong NM, Mercer LD, Flores J, Escarrega EA, Raskin A, Thai DH, Van Be L, Sette A, Innis BL, Krammer F, Weiskopf D
